Neuroinflammatory phenotype in early Alzheimer's disease

被引:161
作者
Sudduth, Tiffany L. [1 ]
Schmitt, Frederick A. [2 ]
Nelson, Peter T. [3 ]
Wilcock, Donna M. [1 ]
机构
[1] Univ Kentucky, Sanders Brown Ctr Aging, Dept Physiol, Lexington, KY 40536 USA
[2] Univ Kentucky, Sanders Brown Ctr Aging, Dept Neurol, Lexington, KY 40536 USA
[3] Univ Kentucky, Sanders Brown Ctr Aging, Dept Pathol, Lexington, KY 40536 USA
基金
美国国家卫生研究院;
关键词
Inflammation; Microglia; Alzheimer's; Clinical trials; Cytokines; NONSTEROIDAL ANTIINFLAMMATORY DRUGS; MIDLIFE BLOOD-PRESSURE; MACROPHAGE ACTIVATION; COGNITIVE IMPAIRMENT; THERAPEUTIC IMPLICATIONS; ALTERNATIVE ACTIVATION; SYSTEMIC INFLAMMATION; DONOR CHARACTERISTICS; NEURITIC PLAQUES; DEMENTIA;
D O I
10.1016/j.neurobiolaging.2012.09.012
中图分类号
R592 [老年病学]; C [社会科学总论];
学科分类号
03 ; 0303 ; 100203 ;
摘要
Alzheimer's disease (AD) involves progressive neurodegeneration in the presence of misfolded proteins and poorly-understood inflammatory changes. However, research has shown that AD is genetically, clinically, and pathologically heterogeneous. In frozen brain samples of frontal cortex (diseased) and cerebellum (nondiseased) from the University of Kentucky Alzheimer's Disease Center autopsy cohort, we performed gene expression analysis for genes categorizing inflammatory states (termed M1 and M2) from early and late stage AD, and age-matched nondemented controls. We performed analysis of the serum samples for a profile of inflammatory proteins and examined the neuropathologic data on these samples. Striking heterogeneity was found in early AD. Specifically, early-stage AD brain samples indicated apparent polarization toward either the M1 or M2 brain inflammatory states when compared with age-matched nondisease control tissue. This polarization was observed in the frontal cortex and not in cerebellar tissue. We were able to detect differences in AD neuropathology, and changes in serum proteins that distinguished the individuals with apparent M1 versus M2 brain inflammatory polarization. (C) 2013 Elsevier Inc. All rights reserved.
引用
收藏
页码:1051 / 1059
页数:9
相关论文
共 39 条
[1]   Inflammation and Alzheimer's disease [J].
Akiyama, H ;
Barger, S ;
Barnum, S ;
Bradt, B ;
Bauer, J ;
Cole, GM ;
Cooper, NR ;
Eikelenboom, P ;
Emmerling, M ;
Fiebich, BL ;
Finch, CE ;
Frautschy, S ;
Griffin, WST ;
Hampel, H ;
Hull, M ;
Landreth, G ;
Lue, LF ;
Mrak, R ;
Mackenzie, IR ;
McGeer, PL ;
O'Banion, MK ;
Pachter, J ;
Pasinetti, G ;
Plata-Salaman, C ;
Rogers, J ;
Rydel, R ;
Shen, Y ;
Streit, W ;
Strohmeyer, R ;
Tooyoma, I ;
Van Muiswinkel, FL ;
Veerhuis, R ;
Walker, D ;
Webster, S ;
Wegrzyniak, B ;
Wenk, G ;
Wyss-Coray, T .
NEUROBIOLOGY OF AGING, 2000, 21 (03) :383-421
[2]   Fallacies in the pathological confirmation of the diagnosis of Alzheimer's disease [J].
Bowler, JV ;
Munoz, DG ;
Merskey, H ;
Hachinski, V .
JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 1998, 64 (01) :18-24
[3]   Risk of dementia and AD with prior exposure to NSAIDs in an elderly community-based cohort [J].
Breitner, J. C. S. ;
Haneuse, S. J. P. A. ;
Walker, R. ;
Dublin, S. ;
Crane, P. K. ;
Gray, S. L. ;
Larson, E. B. .
NEUROLOGY, 2009, 72 (22) :1899-1905
[4]   Extended results of the Alzheimer's disease anti-inflammatory prevention trial [J].
Breitner, John C. ;
Baker, Laura D. ;
Montine, Thomas J. ;
Meinert, Curtis L. ;
Lyketsos, Constantine G. ;
Ashe, Karen H. ;
Brandt, Jason ;
Craft, Suzanne ;
Evans, Denis E. ;
Green, Robert C. ;
Ismail, M. Saleem ;
Martin, Barbara K. ;
Mullan, Michael J. ;
Sabbagh, Marwan ;
Tariot, Pierre N. .
ALZHEIMERS & DEMENTIA, 2011, 7 (04) :402-411
[5]   The suspension of treatments in ADAPT: Concerns beyond the cardiovascular safety of celecoxib or naproxen [J].
Breitner, John C. S. ;
Martin, Barbara K. ;
Meinert, Curtis L. .
PLOS CLINICAL TRIALS, 2006, 1 (08)
[6]   Expression profiles for macrophage alternative activation genes in AD and in mouse models of AD [J].
Colton, Carol A. ;
Mott, Ryan T. ;
Sharpe, Hayley ;
Xu, Qing ;
Van Nostrand, William E. ;
Vitek, Michael P. .
JOURNAL OF NEUROINFLAMMATION, 2006, 3 (1)
[7]   Assessing Activation States in Microglia [J].
Colton, Carol A. ;
Wilcock, Donna M. .
CNS & NEUROLOGICAL DISORDERS-DRUG TARGETS, 2010, 9 (02) :174-191
[8]   Intrahippocampal LPS injections reduce Aβ load in APP+PS1 transgenic mice [J].
DiCarlo, G ;
Wilcock, D ;
Henderson, D ;
Gordon, M ;
Morgan, D .
NEUROBIOLOGY OF AGING, 2001, 22 (06) :1007-1012
[9]   Serum inflammatory proteins and cognitive decline in older persons [J].
Dik, MG ;
Jonker, C ;
Hack, CE ;
Smit, JH ;
Comijs, HC ;
Eikelenboom, P .
NEUROLOGY, 2005, 64 (08) :1371-1377
[10]   Biochemical and functional characterization of three activated macrophage populations [J].
Edwards, Justin P. ;
Zhang, Xia ;
Frauwirth, Kenneth A. ;
Mosser, David M. .
JOURNAL OF LEUKOCYTE BIOLOGY, 2006, 80 (06) :1298-1307